GE HealthCare Technologies Inc. Underwriting AgreementUnderwriting Agreement • August 9th, 2024 • GE HealthCare Technologies Inc. • X-ray apparatus & tubes & related irradiation apparatus
GE HealthCare Technologies Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of $1,000,000,000 principal amount of the 4.800% Senior Notes due 2029 specified above (the “Securities”). The Securities will be issued pursuant to the indenture, dated as of November 22, 2022 (the “Base Indenture”), as supplemented by the Second Supplemental Indenture to be dated on or about August 14, 2024 (the “Second Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), in each case between the Company and The Bank of New York Mellon, as trustee (the “Trustee”).
